DavidRichardShookMDFAAP

Pediatric Hematology & Oncology • San Francisco, CA

Physician

Join to view full profile

Dr. Shook is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shook's full profile

Already have an account?

Office
1975 4th St
San Francisco, CA 94143
Phone+1 415-476-1000

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Pediatrics, 2004 - 2007
Johns Hopkins University School of MedicineClass of 2004
Purdue UniversityBS, Biology, Distinction; Honors Degree, 1996 - 2000

Certifications & Licensure

CA State Medical License 2020 - 2026
FL State Medical License 2015 - 2021
TN State Medical License 2007 - 2015
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Start of enrollment: 2008 Sep 01
Completed
Phase 1
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2009 Oct 01
Completed
Phase 1
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Start of enrollment: 2012 Aug 20
Completed
Phase 1
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas Start of enrollment: 2014 Oct 10
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

6 citations
Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional ...
Aimee C Talleur, Jamie E. Flerlage, David Shook, Abigail M Chilsen, Melissa M. Hudson
Bone Marrow Transplantation. 2020-04-09
11 citations
Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children.
Linda S. Baumgartner, Ernest J. Moore, David Shook, Steven A. Messina, Mary Clare Day
Journal of Audiology & Otology. 2018-08-22
44 citations
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.
Brandon M. Triplett, Brad Muller, Guolian Kang, Ying Li, Shane J Cross
Transplant Infectious Disease. 2018-02-01

Journal Articles

Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell Depletion
Brandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease

Press Mentions

Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
Nkarta Appoints David R. Shook, MD, as Vice President, Clinical DevelopmentMay 16th, 2022
Join now to see all